Impetigo

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Impetigo trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingNot Applicable

NCT07093749

Perspectives on Antibiotics and Tracking Symptoms in Children

The study will assess families' perspectives and decision-making regarding the duration of oral antibiotic courses prescribed to children (4-17 years) who prese…

Australia300 participantsStarted 2025-09-16

Treatment: Garmin Smartwatch

All recent trials (29 shown)

CompletedNot Applicable

NCT07428915

Evaluating Legit.Health Plus Support for Improving Diagnosis of Generalized Pustular Psoriasis and Other Skin Conditions…

This study aims to determine if an artificial intelligence (AI) medical device can help healthcare professionals more accurately diagnose rare and complex skin…

Spain15 participantsStarted 2024-06-01

Treatment: AI-based medical device for aided diagnosis in Dermatology

CompletedNot Applicable

NCT05226260

Decreasing Antibiotic Duration for Skin and Soft Tissue Infection Using Behavioral Economics in Primary Care

Study the efficacy of a package of behavioral economics strategies (versus an education-only control condition) in altering clinician behavior regarding antibio…

United States1,634 participantsStarted 2021-11-01

Treatment: Default Duration order Panel

Impetigo

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Perspectives on Antibiotics and Tracking Symptoms in Children

All recent trials (29 shown)

Evaluating Legit.Health Plus Support for Improving Diagnosis of Generalized Pustular Psoriasis and Other Skin Conditions…

Decreasing Antibiotic Duration for Skin and Soft Tissue Infection Using Behavioral Economics in Primary Care

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Perspectives on Antibiotics and Tracking Symptoms in Children

All recent trials (29 shown)

Evaluating Legit.Health Plus Support for Improving Diagnosis of Generalized Pustular Psoriasis and Other Skin Conditions…

Decreasing Antibiotic Duration for Skin and Soft Tissue Infection Using Behavioral Economics in Primary Care

The Pharmacokinetics of 2% TD1414 Cream in Adults With Secondarily Infected Traumatic Lesions (SITL) or Impetigo

Efficacy, Safety, and Tolerability of TD1414 2% Cream in Impetigo and Secondarily Infected Traumatic Lesions (SITL)

Fucidin® Cream in the Treatment of Impetigo

Efficacy and Safety of Ozenoxacin 1% Cream Versus Placebo in the Treatment of Patients With Impetigo

Safety and Efficacy of Mupirocin Gel in Children With Impetigo

Fiji Integrated Therapy (FIT) - Triple Therapy for Lymphatic Filariasis, Scabies and Soil Transmitted Helminths in Fiji

Surveillance of Streptococcal Infections in Children in India

Azithromycin - Ivermectin Mass Drug Administration for Skin Disease

Tele-dermatology of Skin Cancer in a Cohort of Local Health Authority Employees in the Province of Bergamo

Study Evaluating the Safety, Tolerability, PK, and Activity of Topical ATx201 Gel in Outpatients With Impetigo

Retapamulin Versus Linezolid in the Treatment of SITL and Impetigo Due to MRSA

Topical SB-275833 Ointment, 1% For The Treatment Of Impetigo

Pharmacokinetics of Retapamulin in Pediatric Subjects With Uncomplicated Skin Infections.

Treatment Of Impetigo With Topical SB-275833 Ointment, 1% Versus Topical Placebo Ointment

Efficacy and Safety of Ozenoxacin 1% Cream Versus Placebo in the Treatment of Patients With Impetigo

Twice Daily Altabax Application for the Treatment of Uncomplicated Soft Tissue Infection

ALTARGO(Retapamulin) PMS(Post-marketing Surveillance)

Vehicle Controlled Efficacy and Safety Study of Two Dose Regimens of CD07223 1.5% Topical Gel in Impetigo